… Similar to all viruses, SARS-CoV-2 is constantly evolving; … to spread more efficiently in the
human population or to overcome … antibodies (mAbs) targeting the SARS-CoV-2 spike protein ( …

… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and … In the present study, the
first large-scale survey of antibody … naturally occurring human to cat transmission of SARS-CoV-2. …

… -coronavirus-2 (SARS-CoV-2) Spike receptor-binding domain (RBD)-specific antibodies from
… In addition to increased affinity and neutralization potency, antibody evolution changed the …

… many insights into the human antibody response to the causative SARS-CoV-2 virus. In this
… -induced neutralizing antibodies, and consider vaccine designs for inducing antibodies that …

… therapy and hypogammaglobulinemia we measured serum SARS-CoV-2 specific antibodies
over the course of the admission. Total serum antibodies to SARS-CoV-2 were tested at …

… two human blocking mAbs using SARS-CoV-… SARS-CoV-2 RBD, block the interaction
between SARS-CoV-2 RBD and hACE2 receptor, and lead to efficient neutralization of SARS-CoV-…

… rates of neutralising antibodies compared with binding antibodies against SARS-CoV-2. …
of protective immunity and longevity of neutralising antibodies for SARS-CoV-2. We aimed to …

… antibody made against recombinant SARS coronavirus spike protein and rabbit monoclonal
antibody made against SARS coronavirus … optimal dilution to the SARS-CoV-2 proteins and …

… antibodies and SARS-CoV-2 neutralizing antibodies in patients. Our results, which reveal
the early kinetics of SARS-CoV-2 antibody … specific antibody levels as a correlate of SARS-CoV…

… coronavirus lasts. “17 years later, a SARS survivor still has neutralising antibodies against
SARS—… that not only were the antibodies there, but they could still neutralise the SARS virus.” …